Investigations of the supercoil-selective DNA binding of wild type p53 suggest a novel mechanism for controlling p53 function

被引:37
|
作者
Fojta, M
Pivonkova, H
Brazdova, M
Nemcova, K
Palecek, J
Vojtesek, B
机构
[1] Acad Sci Czech Republ, Inst Biophys, Lab Biophys Chem & Mol Oncol, CZ-61265 Brno, Czech Republic
[2] Univ Hamburg, Dept Tumor Virol, Heinrich Pette Inst Expt Virol & Immunol, Hamburg, Germany
[3] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England
[4] Masaryk Mem Canc Inst, Brno, Czech Republic
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2004年 / 271卷 / 19期
关键词
monoclonal antibodies; p53; latency; redox state; supercoil-selective DNA binding; tumor suppressor protein p53;
D O I
10.1111/j.1432-1033.2004.04323.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor protein, p53, selectively binds to supercoiled (sc) DNA lacking the specific p53 consensus binding sequence (p53CON). Using p53 deletion mutants, we have previously shown that the p53 C-terminal DNA-binding site (CTDBS) is critical for this binding. Here we studied supercoil-selective binding of bacterially expressed full-length p53 using modulation of activity of the p53 DNA-binding domains by oxidation of cysteine residues (to preclude binding within the p53 core domain) and/or by antibodies mapping to epitopes at the protein C-terminus (to block binding within the CTDBS). In the absence of antibody, reduced p53 preferentially bound scDNA lacking p53CON in the presence of 3 kb linear plasmid DNAs or 20 mer oligonucleotides, both containing and lacking the p53CON. Blocking the CTDBS with antibody caused reduced p53 to bind equally to sc and linear or relaxed circular DNA lacking p53CON, but with a high preference for the p53CON. The same immune complex of oxidized p53 failed to bind DNA, while oxidized p53 in the absence of antibody restored selective scDNA binding. Antibodies mapping outside the CTDBS did not prevent p53 supercoil-selective (SCS) binding. These data indicate that the CTDBS is primarily responsible for p53 SCS binding. In the absence of the SCS binding, p53 binds sc or linear (relaxed) DNA via the p53 core domain and exhibits strong sequence-specific binding. Our results support a hypothesis that alterations to DNA topology may be a component of the complex cellular regulatory mechanisms that control the switch between latent and active p53 following cellular stress.
引用
收藏
页码:3865 / 3876
页数:12
相关论文
共 50 条
  • [31] A NOVEL P53 MUTATION WITHIN THE DNA BINDING HOTSPOT
    Austin, Frances
    Massey, Gita
    Corey, Seth
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S87 - S87
  • [32] A mutant P53 can activate apoptosis through a mechanism distinct from those induced by wild type P53
    He, M
    Rennie, PS
    Dragowska, V
    Nelson, CC
    Jia, W
    FEBS LETTERS, 2002, 517 (1-3) : 151 - 154
  • [33] The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53
    Gobert, C
    Skladanowski, A
    Larsen, AK
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) : 10355 - 10360
  • [34] p53CP, a putative p53 competing protein that specifically binds to the consensus p53 DNA binding sites: A third member of the p53 family?
    Bian, JH
    Sun, Y
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) : 14753 - 14758
  • [35] INACTIVE P53 MUTANTS MAY ENHANCE THE TRANSCRIPTIONAL ACTIVITY OF WILD-TYPE P53
    ZHANG, W
    SHAY, JW
    DEISSEROTH, A
    CANCER RESEARCH, 1993, 53 (20) : 4772 - 4775
  • [36] Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53
    M Szybka
    I Zawlik
    D Kulczycka
    E Golanska
    E Jesien
    D Kupnicka
    R Stawski
    S Piaskowski
    E Bieniek
    M Zakrzewska
    R Kordek
    P P Liberski
    P Rieske
    British Journal of Cancer, 2008, 98 : 1431 - 1433
  • [37] Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53
    Szybka, M.
    Zawlik, I.
    Kulczycka, D.
    Golanska, E.
    Jesien, E.
    Kupnicka, D.
    Stawski, R.
    Piaskowski, S.
    Bieniek, E.
    Zakrzewska, M.
    Kordek, R.
    Liberski, P. P.
    Rieske, P.
    BRITISH JOURNAL OF CANCER, 2008, 98 (08) : 1431 - 1433
  • [38] Cloning the P53 DNA Binding Domain
    Jones, Janae
    Faustino, Vroniqa
    Nogaj, Luiza
    FASEB JOURNAL, 2018, 32 (01):
  • [39] P53 degradation by Mdm2 - A novel mechanism for regulation of p53 stability
    Nampoothiri, VK
    CURRENT SCIENCE, 1998, 75 (09): : 875 - 877
  • [40] Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function
    de Vries, A
    Flores, ER
    Miranda, B
    Hsieh, HM
    van Oostrom, CTM
    Sage, J
    Jacks, T
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (05) : 2948 - 2953